10x Genomics Inc (TXG)
22.59
-0.36
(-1.57%)
USD |
NASDAQ |
May 24, 16:00
22.52
-0.07
(-0.31%)
After-Hours: 20:00
10x Genomics Free Cash Flow: -73.95M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -73.95M |
| December 31, 2023 | -64.72M |
| September 30, 2023 | -113.04M |
| June 30, 2023 | -118.44M |
| March 31, 2023 | -125.74M |
| December 31, 2022 | -165.27M |
| September 30, 2022 | -161.07M |
| June 30, 2022 | -161.38M |
| March 31, 2022 | -128.64M |
| Date | Value |
|---|---|
| December 31, 2021 | -122.65M |
| September 30, 2021 | -253.28M |
| June 30, 2021 | -263.78M |
| March 31, 2021 | -288.58M |
| December 31, 2020 | -256.29M |
| September 30, 2020 | -103.73M |
| June 30, 2020 | -45.94M |
| March 31, 2020 | -18.75M |
| December 31, 2019 | -8.14M |
Free Cash Flow Range, Past 5 Years
-288.58M
Minimum
Mar 2021
-8.14M
Maximum
Dec 2019
-137.41M
Average
-124.19M
Median
Free Cash Flow Benchmarks
| Teladoc Health Inc | 199.55M |
| American Shared Hospital Services | -5.155M |
| Novo Integrated Sciences Inc | -4.952M |
| Astrana Health Inc | 52.44M |
| Cryo-Cell International Inc | -0.8021M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.72M |
| Cash from Investing (Quarterly) | 10.63M |
| Cash from Financing (Quarterly) | 1.638M |
| Free Cash Flow Per Share (Quarterly) | -0.1561 |
| Free Cash Flow to Equity (Quarterly) | -18.64M |
| Free Cash Flow to Firm (Quarterly) | -18.64M |
| Free Cash Flow Yield | -2.77% |